Navigation Links
Synthetic Biologics Appoints Carol Reed, M.D., as Senior Vice President of Clinical & Regulatory Affairs
Date:5/14/2012

ANN ARBOR, Mich., May 14, 2012 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE Amex: SYN), a developer of synthetic DNA-based therapeutics and innovative disease-modifying medicines for serious illnesses, announced today the appointment of Carol Reed, M.D., as Senior Vice President of Clinical & Regulatory Affairs. In this position, Dr. Reed will be responsible for the design and implementation of all aspects of clinical development, including clinical trials, and will lead the Company's regulatory initiatives. Dr. Reed brings over 25 years of experience, in medical practice and in the biotechnology/pharmaceutical sector, including six years with Clinical Data, Inc., a publicly-traded biopharmaceutical company which was acquired by Forest Laboratories, Inc.

Most recently, Dr. Reed served as Chief Medical Officer at Clinical Data, Inc. from 2005 through 2011, after the company merged with Genaissance Pharmaceuticals, Inc., where she had served as Vice President, Medical Affairs since 2003. During her tenure at Clinical Data, Inc., Dr. Reed was responsible for the design and management of two successful consecutive Phase III clinical trials for VIIBRYD® which is used in the treatment of major depressive disorder in adults. These efforts led to the approval of VIIBRYD in January 2011 by the U.S. Food and Drug Administration. Prior to this time, Dr. Reed served as Associate Medical Director in Pulmonary Medical Research at Bayer Pharmaceuticals, Inc. Previously, she was the Associate Director, Section of Pulmonary and Critical Care Medicine at the Hospital of St. Raphael and directed its Medical Intensive Care Unit.

"We are very pleased to add an executive of Carol's caliber to the Synthetic Biologics' team. Carol's broad experience in clinical development, as well as her leadership skills, are expected to be tremendous assets to the Company as we continue to
'/>"/>

SOURCE Synthetic Biologics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Inovio Pharmaceuticals Granted U.S. Patent Protection for Synthetic Vaccine for Cervical Dysplasia and Cancer
2. Stemline Therapeutics Announces Two Presentations of Direct Injection Synthetic Peptide Vaccine for Brain Cancer, Now Being Developed as SL-701, at the Annual Meeting of the American Association of Cancer Research (AACR)
3. Adeona Announces Executive Management Transitions and Board of Directors Appointments to Strengthen Companys Synthetic Biologics Strategic Focus
4. Synthetic Genomics, Inc. and Integrated DNA Technologies, Inc. Sign Agreement to Manufacture, Market, and Commercialize Small Synthetic Gene Products Using SGI Technology
5. Adeona Announces Proposed Name Change to Synthetic Biologics, Inc., and Appointment of John Monahan, Ph.D., as Senior Vice President of Research & Development
6. Adeona Pharmaceuticals and Intrexon Announce Worldwide Exclusive Collaboration for Synthetic DNA-based Therapy for Pulmonary Arterial Hypertension
7. Inovio Pharmaceuticals and VGX International to Advance Therapeutic Hepatitis C and Hepatitis B Synthetic Vaccines into Clinical Studies
8. Inovio Pharmaceuticals Synthetic Vaccine for Cancer Recognized as Most Promising Research at Global Vaccine Congress
9. Synthetic Genomics Vaccines, Inc. Hires Vaccine Executive Sammy J. Farah as President
10. Inovio Pharmaceuticals Enters Collaboration With U.S. Dept. of Homeland Security to Assess Foot & Mouth Disease Synthetic Vaccines Potential to Help Ensure Nations Food Supply Safety
11. Novus Scientific Announces the Worlds 1st Long-Term Absorbable Mesh as an Alternative to Non-Absorbable Synthetic Mesh
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... MERIDIAN, Idaho , Jan. 23, 2015  Now available ... Patent No. 7,849,611) support that prevents ankle sprains by ... a brace, it fits securely around the outside of ... ankle mobility & comfort while still offering protection against ...
(Date:1/23/2015)... Blood America, Inc. ( www.cordblood-america.com ) (OTC Bulletin Board: ... Proxy Statement, Schedule 14A, with the U.S. Securities & Exchange ... shareholders detailing why a "YES" vote to increase the number ... As we reflect upon the 2014 fiscal year that ...
(Date:1/23/2015)... , Jan. 23, 2015  Mallinckrodt plc (NYSE: ... Directors has approved a share repurchase program. The open-ended ... million of Mallinckrodt plc ordinary shares. ... remain top priorities as we continue to pursue a ...
Breaking Medicine Technology:The Armor1 Ankle Roll Guard is the New Breakthrough Solution for Ankle Sprain Prevention! 2Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 2Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 3Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 4Mallinckrodt plc Announces Share Repurchase Program 2Mallinckrodt plc Announces Share Repurchase Program 3Mallinckrodt plc Announces Share Repurchase Program 4
... Mass., March 19, 2012  Oridion (SIX Swiss Exchange: ... of the Smart Capnography™ family of decision-support solutions, ... survey conducted at the October 2011 annual meeting ... in Chicago. Respondents showed a clear preference for monitoring ...
... Fla., March 19, 2012   SurgLine International, Inc. (SGLN.PK) ... and certain consultants to SGLN and SurgLine have completed the ... Company.  This announcement is the follow up to the previous ... an additional six month lock up of the restricted shares ...
Cached Medicine Technology:Survey Shows Anesthesiologists Prefer Capnography for Monitoring Adequacy of Ventilation 2Survey Shows Anesthesiologists Prefer Capnography for Monitoring Adequacy of Ventilation 3Survey Shows Anesthesiologists Prefer Capnography for Monitoring Adequacy of Ventilation 4SurgLine International, Inc. Announces Over 1 Billion Shares Returned to Company 2
(Date:1/22/2015)... Payday lending practices in four southern states ... distress to the states that permit them, according to ... on Race and Wealth. , While they generate hundreds ... at the same time substantially depress economic activity, according ...
(Date:1/22/2015)... January 22, 2015 As interest in the ... care gains momentum worldwide, Rev. Eric J. Hall , ... Network (HCCN), will be the keynote speaker on January ... Israel’s public health system. , The conference, “Hope and Resilience: ...
(Date:1/22/2015)... 2015 Compare-autoinsurance.org has released a new blog post ... auto insurance policy . , Some types of vehicles ... check the newly released blog post to see if their vehicle ... damaged vehicles are some of the cars that cannot be covered ...
(Date:1/22/2015)... Step into a macabre world where plants hold ... Wicked Plants, the Museum’s latest featured exhibition, opens Saturday, ... and diabolical plants inside of a dilapidated, Victorian home. ... physical and neurological processes between botanicals and the human ...
(Date:12/26/2014)... 26, 2014 The US represents the largest ... In 2013, GlobalData’s forecast estimates that sales of branded therapies ... due to the high incidence of the disease, high drug ... Japan, and China. Increased sales of CRC therapies over the ...
Breaking Medicine News(10 mins):Health News:Howard University Spotlights the Economic Impact of Payday Lending in Southern States 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 3Health News:Some Vehicles Cannot Be Covered By An Auto Insurance Policy! 2Health News:Wicked Plants are taking over the Science Museum of Virginia 2Health News:US Colorectal Cancer Drug Market Analysis and Forecast to 2023 Report Available at ReportsnReports.com 2Health News:US Colorectal Cancer Drug Market Analysis and Forecast to 2023 Report Available at ReportsnReports.com 3Health News:US Colorectal Cancer Drug Market Analysis and Forecast to 2023 Report Available at ReportsnReports.com 4
... of trying to "privatise the NHS by stealth" after ... companies to apply for the management of the healthcare ... contract in the Official Journal of the European Union ... the vision and step change from a service-provider to ...
... reconsidering recent changes in visa rules that in effect make ... the National Health Service. ,The department of health (DoH) ... system by which employers would need to prove that no ... for someone from outside the European Union. ,This ...
... been detected in Moga out of which 52 were male ... ,The infected people were found during a survey ... Dr H P S Sandhu told reporters here., ,The ... doctor and the local clinical laboratory, 12 cases were found ...
... ,Recent research has further confirmed the theory that environmental ... for diabetes //in children and young adults. ... Universities and Leeds Teaching Hospitals NHS Trust, carried out ... on the times and places where the children and ...
... nurses would need to have work permits in order to take ... taken to give jobs to the homegrown nursing graduates. Statistics show ... European Union every year. ,India supplied the most number ... to nurses in bands 5 and 6. But the Royal College ...
... a research conducted by Dr. Bing-Huei Chen and colleagues ... unhealthy cholesterol //compounds that form during cooking. ... Taipei, Taiwan. Cholesterol Oxidation Products (COPs) is produced when ... are deleterious and affect the body cells leading to ...
Cached Medicine News:Health News:Government Accused Of Yielding NHS To Outside Interests 2Health News:Britain Reconsidering New Visa Rules for Indian Doctors 2Health News:Environmental Factors Trigger Onset of Diabetes 2
... ENA assays can be used to ... antibodies, which are associated with various ... lupus erythematosus (Lupus), Sjgren's syndrome, mixed ... scleroderma, polymyositis, dermatomyositis, and Raynaud's phenomenon. ...
... commonly prescribed for the prevention of life threatening ... However, a number of studies have shown that ... aspirin therapy to prevent a recurrent vascular event ... These people are at greater risk for a ...
... System is an embolic protection device that ... debris that may be dislodged during interventional ... components. The first is a guidewire-mounted filter, ... Other ancillary components supplied with the system ...
... is a simulator for intraocular surgery. The ... surgeon the feeling that he is experiencing ... surgeon uses instruments that feel and function ... through the EYESI microscope is similar to ...
Medicine Products: